Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists are Hypocrites.

Miller LG.

Clin Infect Dis. 2018 Aug 23. doi: 10.1093/cid/ciy720. [Epub ahead of print] No abstract available.

PMID:
30137243
2.

Lack of uniformity among United States recommendations for diagnosis and management of acute, uncomplicated cystitis.

Markowitz MA, Wood LN, Raz S, Miller LG, Haake DA, Kim JH.

Int Urogynecol J. 2018 Aug 11. doi: 10.1007/s00192-018-3750-z. [Epub ahead of print]

PMID:
30099566
3.

Patient contact is the main risk factor for vancomycin-resistant Enterococcus contamination of healthcare workers' gloves and gowns in the intensive care unit.

Jackson SS, Thom KA, Magder LS, Stafford KA, Johnson JK, Miller LG, Calfee DP, Harris AD; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1063-1067. doi: 10.1017/ice.2018.160. Epub 2018 Jul 27.

PMID:
30051793
4.

Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.

Richter SE, Miller L, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00149-18. doi: 10.1128/JCM.00149-18. Print 2018 Sep.

PMID:
29976595
5.

Pregnancy screening and monitoring of Albendazole therapy for Neurocysticercosis.

Persichino JG, Miller LG.

Clin Infect Dis. 2018 May 22. doi: 10.1093/cid/ciy436. [Epub ahead of print] No abstract available.

PMID:
29790912
6.

The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae Toolkit.

Bartsch SM, Huang SS, McKinnell JA, Wong KF, Mueller LE, Miller LG, Lee BY.

Infect Control Hosp Epidemiol. 2018 May;39(5):516-524. doi: 10.1017/ice.2018.49. Epub 2018 Mar 19.

7.

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.

O'Riordan W, McManus A, Teras J, Poromanski I, Cruz-Saldariagga M, Quintas M, Lawrence L, Liang S, Cammarata S; PROCEED Study Group .

Clin Infect Dis. 2018 Aug 16;67(5):657-666. doi: 10.1093/cid/ciy165.

8.

Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.

Dillen CA, Pinsker BL, Marusina AI, Merleev AA, Farber ON, Liu H, Archer NK, Lee DB, Wang Y, Ortines RV, Lee SK, Marchitto MC, Cai SS, Ashbaugh AG, May LS, Holland SM, Freeman AF, Miller LG, Yeaman MR, Simon SI, Milner JD, Maverakis E, Miller LS.

J Clin Invest. 2018 Mar 1;128(3):1026-1042. doi: 10.1172/JCI96481. Epub 2018 Feb 5.

9.

A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis.

Connolly LE, Riddle V, Cebrik D, Armstrong ES, Miller LG.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01989-17. doi: 10.1128/AAC.01989-17. Print 2018 Apr.

10.

Cephalexin plus trimethoprim-sulfamethoxazole was not superior to cephalexin alone for the treatment of outpatient non-purulent cellulitis.

Miller LG.

Evid Based Med. 2017 Dec;22(6):213. doi: 10.1136/ebmed-2017-110796. Epub 2017 Nov 10. Review. No abstract available.

PMID:
29127212
11.

A Case of Early Prosthetic Valve Endocarditis Caused by Staphylococcus warneri in a Patient Presenting With Congestive Heart Failure.

Kuvhenguhwa MS, Belgrave KO, Shah SU, Bayer AS, Miller LG.

Cardiol Res. 2017 Oct;8(5):236-240. doi: 10.14740/cr588w. Epub 2017 Oct 27.

12.

Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal Swabs.

Yarbrough ML, Warren DK, Allen K, Burkholder D, Daum R, Donskey C, Knaack D, LaMarca A, May L, Miller LG, Parenti DM, Peterson L, Tan TY, Widen R, Hernandez DR, Wolk DM, Burnham CA.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01381-17. doi: 10.1128/JCM.01381-17. Print 2018 Jan.

13.

Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?

Humphries RM, Hindler JA, Epson E, Horwich-Scholefield S, Miller LG, Mendez J, Martinez JB, Sinkowitz J, Sinkowtiz D, Hershey C, Marquez P, Bhaurla S, Moran M, Pandes L, Terashita D, McKinnell JA.

Clin Infect Dis. 2018 Mar 19;66(7):1061-1067. doi: 10.1093/cid/cix942.

PMID:
29099915
14.

A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.

Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF; DMID 07-0051 Team.

N Engl J Med. 2017 Jun 29;376(26):2545-2555. doi: 10.1056/NEJMoa1607033.

15.

Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.

Doernberg SB, Lodise TP, Thaden JT, Munita JM, Cosgrove SE, Arias CA, Boucher HW, Corey GR, Lowy FD, Murray B, Miller LG, Holland TL; Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG).

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828. Review.

16.

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.

Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators.

N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.

17.

Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.

Johnson JR, Johnston B, Thuras P, Launer B, Sokurenko EV, Miller LG.

mSphere. 2016 Nov 23;1(6). pii: e00314-16. eCollection 2016 Nov-Dec.

18.

Therapy for Cellulitis.

Miller LG.

JAMA. 2016 Nov 15;316(19):2046. doi: 10.1001/jama.2016.15610. No abstract available.

PMID:
27838714
19.

Status of the Prevention of Multidrug-Resistant Organisms in International Settings: A Survey of the Society for Healthcare Epidemiology of America Research Network.

Safdar N, Sengupta S, Musuuza JS, Juthani-Mehta M, Drees M, Abbo LM, Milstone AM, Furuno JP, Varman M, Anderson DJ, Morgan DJ, Miller LG, Snyder GM; SHEA Research Committee.

Infect Control Hosp Epidemiol. 2017 Jan;38(1):53-60. doi: 10.1017/ice.2016.242. Epub 2016 Nov 7.

PMID:
27817759
20.

Prevalence of and Factors Associated With Multidrug Resistant Organism (MDRO) Colonization in 3 Nursing Homes.

McKinnell JA, Miller LG, Singh R, Kleinman K, Peterson EM, Evans KD, Dutciuc TD, Heim L, Gombosev A, Estevez M, Launer B, Tjoa T, Tam S, Bolaris MA, Huang SS.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1485-1488. Epub 2016 Sep 27.

PMID:
27671022

Supplemental Content

Loading ...
Support Center